Sarsia Seed invests in early-stage science and technology based companies operating in the areas of Energy / Technology and Biotechnology / Life Sciences. A typical first round of investment will be in the area of 2-5 million NOK for a 10% to 40% ownership stake. The fund always allocate capital for follow on investments as the company matures. Sarsia Seed is keen to attract co-investments from professional and/or corporate investors as early as possible so as to carry prospects forward at the fastest possible pace.
Early-stage start-up companies look for more than just financial support from their investors. Thus, we aim to add value to our investments by contributing our expertise towards the companies’ technological and/or commercial development. Sarsia Seed is primarily looking for companies with an attachment to Norway but may also invest in European based companies if the fit is good.
- Biomedicine and Biotechnology
- Medical instrumentation and technology platforms
- Medical diagnostics and other biotechnology products
- Marine and aquaculture technology
Sensors, Analytics, Industrial IoT
Material technology, solar, battery, sustainable production technologies
Electric power analytics, control and monitoring technologies
Technologies for energy production, efficient use and distribution
Advanced analytics, machine learning, AI, hardware and Software service models.
Sarsia is a signatory of the UN Principles for Responsible Investment (PRI) and a member of Norsif.
Sarsia supports the Paris Agreement, the UN SDG’s and the work of TFCD.